TF-depletion, pharmacological targeting TF or mTORC1/2 in the tumor all enhanced infiltration of M1-macrophage and M1-derived pro-inflammatory activation markers, while diminished M2-related anti-inflammatory markers. This evidence concerns the gene TF and neoplasm.